Table 1.

In vitro studies demonstrating half maximal inhibitory concentration values of baicalein against several types of malignancies.

Cell Lines	Type of Cancer	Assay	Time	Dose, IC50 [μM]	Ref.
QBC939	Cholangiocarcinoma	CCK-8	72 h	32.73	[37]
MGC-803	Gastric cancer	MTT	48 h	85.70	[30]
HT-29	Colorectal cancer	MTS	72 h	40	[38]
RPMI 8226	Myeloma	MTT	24 h	168.5	[39]
BEL-7402	Hepatocellular carcinoma	MTT	48 h	54.96	[40]
MCF-7	Breast cancer	MTT	72 h	CC50 = 56.46 μM	[41]
U2OS	Osteosarcoma	MTT	48 h	53	[42]
CNE1	Nasopharyngeal cancer	MTT	144 h	20.95	[32]
C33A	Cervical cancer	MTT	96 h	200	[44]